semaglutide compound fda approved Hims & Hers stock falls 25% as curtails compounded GLP-1s FDA alerts health care providers,

For patients considering GLP-1 medications or currently taking them, its worth having a conversation with your healthcare team about muscle health

( Epub 2016/03/20 )

Patients should discuss all options with a health care provider before making a decision

CLICK HERE TO GET THE FOX NEWS APP "The study collects health information on pregnant women and their babies up to 1 year of age from enrolled pregnant women themselves and the health care providers involved in their care or the care of their babies." The Wegovy website states that the medication "may cause fetal harm" and advises women to discontinue use if they become pregnant.

As with any prescription treatment, the determination of whether GLP-1 therapy is appropriate rests with a qualified clinician evaluating your individual health profile